Renée de Leeuw, PhD
Postdoctoral Fellow, Cancer Biology
Thomas Jefferson University
As for many of us, my drive to study cancer stems from this devastating disease affecting people close to me, including my grandmother who passed away from the consequences of breast cancer while I was in grad school. After finishing my graduate studies on molecular understanding of tamoxifen resistance in breast cancer at the Netherlands Cancer Institute in my home country, I moved to the US and made the transition to the prostate cancer field, joining Dr. Karen Knudsen’s laboratory at Thomas Jefferson University. My research interests encompass understanding mechanisms of therapeutic resistance, discovering novel metrics to predict treatment outcome, and defining new therapeutic strategies to treat advanced, drug-resistant diseases.
As a translational cancer researcher I am particularly thrilled not only to see my findings rapidly translated to the clinical setting, but also to collaborate with the clinicians who perform the clinical trials based on my preclinical findings. My goal is to develop an independent research program and start my own lab in academia committed to the improvement of durable outcomes for advanced prostate cancer patients. I enjoy working in multidisciplinary teams, and I aim to become a leader in my field. I understand it takes more than excellent lab skills to succeed, and therefore, I continue to seek out opportunities to improve my professional skills. I am excited about joining the Associate Member Council and am dedicated to stimulating the career development of early-career scientists by sharing my own experiences and coming up with new ideas for career advancement sessions. I believe this is key to a strong scientific community with a shared drive to cure cancer.